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Response: A Critique of the International Association for the
Study of Lung Cancer Lymph Node Map
Valerie W. Rusch, MD,* and Hisao Asamura, MD†
We thank Pitson et al.1 for providing a detailed analysis ofthe International Association for the Study of Lung
Cancer (IASLC) lymph node map from the viewpoint of
radiation oncologists. The objectives of this map2 were to
reconcile differences between the Japanese and MD-ATS
(American Thoracic Society as modified by Mountain and
Dresler) maps and to provide more specific anatomic defini-
tions for each of the lymph node stations. Although the map
was developed with multidisciplinary input from the IASLC
Staging Committee including radiologists and radiation on-
cologists, additional thoughts are always welcome. We pro-
vide a few specific comments in response:
1. The authors raise a concern that the anatomic boundar-
ies for stations 1 and 2 lymph nodes may be unclear
because of potentially variable location of the clavicle
and the apex of the lung (presumably with respiration).
In clinical practice, however, the distinction between
supraclavicular (station 1) and high paratracheal (sta-
tion 2) lymph nodes is usually straightforward on phys-
ical examination and computed tomography (CT) scan.
As station 2 lymph nodes tend to be very close to the
midline, their location is static and not prone to variable
position with respiration.
2. We agree with Dr. Pitson that it is important to distin-
guish between stations 4 and 10 and considerable effort
was made to provide clearer definitions in the IASLC
map for these stations as well as for station 7. Distal
pretracheal lymph nodes are located above the lower
border of the azygos vein and are considered 4R and not
10 (Table 1 and Figure 3 in Ref. 2). The authors are
correct that station 7 encompasses a larger area than
previously. This change reconciled one of the major
differences between the Japanese and MD-ATS maps.
3. We agree that although separation of stations 8 and 9 is
straightforward at surgery, it could be difficult on CT,
especially if extensive adenopathy is present. Coronal
CT views may be helpful in this regard.
4. While separation of stations 10 (around the main bron-
chi) and 11 (interlobar) could conceivably be difficult in
situations where there is bulky or confluent N1 disease,
these are two anatomically distinct regions that should
not be merged routinely.
Suggestions for revisions to the IASLC map would
certainly be welcomed by the International Staging Commit-
tee. However, it is important that such suggestions should
recommend specific alternative definitions to anatomical
boundaries as they are currently and not merely be critiques.
Changes need to be applicable to all disciplines involved in
the care of lung cancer patients and be internationally accept-
able and meaningful in daily clinical care.
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